152 related articles for article (PubMed ID: 11999190)
1. Recent developments on human cell lines for the bioartificial liver.
Hoekstra R; Chamuleau RA
Int J Artif Organs; 2002 Mar; 25(3):182-91. PubMed ID: 11999190
[TBL] [Abstract][Full Text] [Related]
2. Which are the right cells to be used in a bioartificial liver?
Chamuleau RA; Deurholt T; Hoekstra R
Metab Brain Dis; 2005 Dec; 20(4):327-35. PubMed ID: 16382343
[TBL] [Abstract][Full Text] [Related]
3. Selecting Cells for Bioartificial Liver Devices and the Importance of a 3D Culture Environment: A Functional Comparison between the HepaRG and C3A Cell Lines.
van Wenum M; Adam AA; Hakvoort TB; Hendriks EJ; Shevchenko V; van Gulik TM; Chamuleau RA; Hoekstra R
Int J Biol Sci; 2016; 12(8):964-78. PubMed ID: 27489500
[TBL] [Abstract][Full Text] [Related]
4. Advances in cell sources of hepatocytes for bioartificial liver.
Pan XP; Li LJ
Hepatobiliary Pancreat Dis Int; 2012 Dec; 11(6):594-605. PubMed ID: 23232630
[TBL] [Abstract][Full Text] [Related]
5. Improved survival of porcine acute liver failure by a bioartificial liver device implanted with induced human functional hepatocytes.
Shi XL; Gao Y; Yan Y; Ma H; Sun L; Huang P; Ni X; Zhang L; Zhao X; Ren H; Hu D; Zhou Y; Tian F; Ji Y; Cheng X; Pan G; Ding YT; Hui L
Cell Res; 2016 Feb; 26(2):206-16. PubMed ID: 26768767
[TBL] [Abstract][Full Text] [Related]
6. HepaRG-Progenitor Cell Derived Hepatocytes Cultured in Bioartificial Livers Are Protected from Healthy- and Acute Liver Failure-Plasma Induced Toxicity.
van Wenum M; Treskes P; Adam AAA; van der Mark VA; Jongejan A; Moerland PD; van Gulik TM; Oude Elferink RPJ; Chamuleau RAFM; Hoekstra R
Cell Physiol Biochem; 2018; 48(5):2189-2204. PubMed ID: 30110678
[TBL] [Abstract][Full Text] [Related]
7. Proliferative human cell sources applied as biocomponent in bioartificial livers: a review.
Nibourg GA; Chamuleau RA; van Gulik TM; Hoekstra R
Expert Opin Biol Ther; 2012 Jul; 12(7):905-21. PubMed ID: 22650303
[TBL] [Abstract][Full Text] [Related]
8. Biologic liver support: optimal cell source and mass.
Morsiani E; Brogli M; Galavotti D; Pazzi P; Puviani AC; Azzena GF
Int J Artif Organs; 2002 Oct; 25(10):985-93. PubMed ID: 12456040
[TBL] [Abstract][Full Text] [Related]
9. Functional hepatocyte clusters on bioactive blend silk matrices towards generating bioartificial liver constructs.
Janani G; Nandi SK; Mandal BB
Acta Biomater; 2018 Feb; 67():167-182. PubMed ID: 29223705
[TBL] [Abstract][Full Text] [Related]
10. Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes.
Soto-Gutiérrez A; Kobayashi N; Rivas-Carrillo JD; Navarro-Alvarez N; Zhao D; Okitsu T; Noguchi H; Basma H; Tabata Y; Chen Y; Tanaka K; Narushima M; Miki A; Ueda T; Jun HS; Yoon JW; Lebkowski J; Tanaka N; Fox IJ
Nat Biotechnol; 2006 Nov; 24(11):1412-9. PubMed ID: 17086173
[TBL] [Abstract][Full Text] [Related]
11. Liver progenitor cell line HepaRG differentiated in a bioartificial liver effectively supplies liver support to rats with acute liver failure.
Nibourg GA; Chamuleau RA; van der Hoeven TV; Maas MA; Ruiter AF; Lamers WH; Oude Elferink RP; van Gulik TM; Hoekstra R
PLoS One; 2012; 7(6):e38778. PubMed ID: 22719943
[TBL] [Abstract][Full Text] [Related]
12. Ammonia metabolism capacity of HepG2 cells with high expression of human glutamine synthetase.
Tang NH; Wang XQ; Li XJ; Chen YL
Hepatobiliary Pancreat Dis Int; 2008 Dec; 7(6):621-7. PubMed ID: 19073408
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Nafamostat Mesilate for improving the performance of a bioartificial liver using porcine hepatocytes.
Fujioka H; Eguchi S; Sugiyama N; Kawazoe Y; Kawashita Y; Kamohara Y; Azuma T; Furui J; Kanematsu T
Int J Artif Organs; 1999 Jul; 22(7):505-10. PubMed ID: 10493559
[TBL] [Abstract][Full Text] [Related]
14. Bioartificial livers in vitro and in vivo: tailoring biocomponents to the expanding variety of applications.
van Wenum M; Chamuleau RA; van Gulik TM; Siliakus A; Seppen J; Hoekstra R
Expert Opin Biol Ther; 2014 Dec; 14(12):1745-60. PubMed ID: 25366164
[TBL] [Abstract][Full Text] [Related]
15. Increased hepatic functionality of the human hepatoma cell line HepaRG cultured in the AMC bioreactor.
Nibourg GA; Hoekstra R; van der Hoeven TV; Ackermans MT; Hakvoort TB; van Gulik TM; Chamuleau RA
Int J Biochem Cell Biol; 2013 Aug; 45(8):1860-8. PubMed ID: 23770120
[TBL] [Abstract][Full Text] [Related]
16. Liver support therapy: an overview of the AMC-bioartificial liver research.
van de Kerkhove MP; Poyck PP; Deurholt T; Hoekstra R; Chamuleau RA; van Gulik TM
Dig Surg; 2005; 22(4):254-64. PubMed ID: 16174982
[TBL] [Abstract][Full Text] [Related]
17. Porcine endogenous retrovirus released by a bioartificial liver infects primary human cells.
Frühauf JH; Mertsching H; Giri S; Frühauf NR; Bader A
Liver Int; 2009 Nov; 29(10):1553-61. PubMed ID: 19686312
[TBL] [Abstract][Full Text] [Related]
18. Stable overexpression of pregnane X receptor in HepG2 cells increases its potential for bioartificial liver application.
Nibourg GA; Huisman MT; van der Hoeven TV; van Gulik TM; Chamuleau RA; Hoekstra R
Liver Transpl; 2010 Sep; 16(9):1075-85. PubMed ID: 20818746
[TBL] [Abstract][Full Text] [Related]
19. Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver.
Nyberg SL; Remmel RP; Mann HJ; Peshwa MV; Hu WS; Cerra FB
Ann Surg; 1994 Jul; 220(1):59-67. PubMed ID: 8024360
[TBL] [Abstract][Full Text] [Related]
20. Use of a rotary bioartificial liver in the differentiation of human liver stem cells.
Fonsato V; Herrera MB; Buttiglieri S; Gatti S; Camussi G; Tetta C
Tissue Eng Part C Methods; 2010 Feb; 16(1):123-32. PubMed ID: 19397473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
